Clinicopathological characteristics of human epidermal growth factor receptor 2-positive Barrett's adenocarcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 43

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

360

HTML

2445

Figures (1-1)

154

Tables (1-2)

143

Sum=3102

Nov 21, 2012 (publication date) through Jul 17, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Nov 21, 2012; 18(43): 6263-6268
Published online Nov 21, 2012. doi: 10.3748/wjg.v18.i43.6263

Table 1 Patient and tumor characteristics

Characteristics	Values
Male/female	20/10
Age, yr (mean ± SD)	71.1 ± 9.7
Surgical resection/endoscopic resection	14/16
Location: Siewert I/II	12/18
Tumor size, mm (mean ± SD)	27.1 ± 19.9
Depth of primary tumor: T1a/T1b/T2/T3/T4	13/13/1/2/1
Macroscopic appearance: 0-I/0-IIa/0-IIb/0-IIc/3	8/8/1/11/3
Histology: tub1/tub2	21/9
Histology tub1/tub2: mucin phenotype G/GI/I/N	7/12/8/3
p53: positive/negative	20/10

G: Gastric phenotype; GI: Gastrointestinal phenotype; I: Intestinal phenotype; N: Null type.

Citation: Tanaka T, Fujimura A, Ichimura K, Yanai H, Sato Y, Takata K, Okada H, Kawano S, Tanabe S, Yoshino T. Clinicopathological characteristics of human epidermal growth factor receptor 2-positive Barrett's adenocarcinoma. World J Gastroenterol 2012; 18(43): 6263-6268
URL: https://www.wjgnet.com/1007-9327/full/v18/i43/6263.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i43.6263